EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 37 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $39,000 | – | 18,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 41,909,219 | $21,793,000 | 11.58% |
| Kore Private Wealth LLC | 202,366 | $105,000 | 0.02% |
| BARD ASSOCIATES INC | 335,750 | $175,000 | 0.02% |
| HighTower Advisors, LLC | 5,284,688 | $2,738,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 126,529 | $66,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 654,200 | $339,000 | 0.01% |
| Virtu Financial LLC | 57,076 | $30,000 | 0.01% |
| WEDBUSH SECURITIES INC | 81,500 | $42,000 | 0.00% |
| MATRIX ASSET ADVISORS INC/NY | 39,500 | $20,000 | 0.00% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 33,933 | $18,000 | 0.00% |